Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 20, 2011
Patent Application Number
12558312
Date Filed
September 11, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides antagonizing antibodies, antigen-binding portions thereof, and aptamers that bind to proprotein convertase subtilisin kexin type 9 (PCSK9). Also provided are antibodies directed to peptides, in which the antibodies bind to PCSK9. The invention further provides a method of obtaining such antibodies and antibody-encoding nucleic acid. The invention further relates to therapeutic methods for use of these antibodies and antigen-binding portions thereof to reduce LDL-cholesterol levels and/or for the treatment and/or prevention of cardiovascular disease, including treatment of hypercholesterolemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
